Author: Lynne Taylor

The European Commission has confirmed that its investigators carried out new surprise raids yesterday (December 9) on the offices of a number of drugmakers, as part of its investigations into alleged antitrust activities in the sector.

Reports claiming that US prescription drug prices have been rising significantly, ahead of the government’s planned health reforms, are misleading and biased, Congress has been told.

The government/industry cost-sharing scheme for four multiple sclerosis (MS) drugs, begun in 2002 after NICE rejected them on cost-effectiveness grounds, has failed so far to show whether or not they represent value for money, says a new study.

Chancellor Alastair Darling is set to announce “delays” to parts of the £12 billion NHS IT project in England in his pre-Budget Report tomorrow (December 9).

The Council of the European Union (EU) has announced a “breakthrough” agreement on long-awaited plans for a single EU Patent and a new European patent court.